Sessa Capital IM »

Atrium Therapeutics shares owned by Sessa Capital IM

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Sessa Capital IM from 13F filings

Historical chart of Sessa Capital IM investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by Sessa Capital IM consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by Sessa Capital IM

Quarter filed Position value Share count Share price at filing
2026-03-31 $7.4M 551k 13.37

More positions owned by Sessa Capital IM

Warner Bros Discovery Com Ser A (WBD)
Humana (HUM)
PG&E Corporation (PCG)
Kimberly-Clark Corporation (KMB)
Illumina (ILMN)
Air Products & Chemicals (APD)
Ally Financial (ALLY)
Sotera Health (SHC)
Capital One Financial (COF)
Solstice Advanced Matls Com Shs (SOLS)
Teleflex Incorporated (TFX)
Ftai Aviation SHS (FTAI)
Coupang Cl A (CPNG)
Tandem Diabetes Care Com New (TNDM)
Grail (GRAL)

View all positions for Sessa Capital IM

Top funds holding Atrium Therapeutics

BlackRock
RA Capital Management
Vanguard Capital Management
TIG Advisors
Pentwater Capital Management
Sessa Capital IM
Goldman Sachs Group
Vanguard Portfolio Management
Geode Capital Management
683 Capital Management
Weiss Asset Management LP[1
Cantor Fitzgerald, L. P.
Balyasny Asset Management
Squarepoint Ops
Fort Hoosac Management

View all funds holding Atrium Therapeutics